Nutropin AQ

DRUG6 trials

Sponsors

The University of Texas Health Science Center at San Antonio, Children's Hospital Los Angeles, Oregon Health and Science University, University of Texas Southwestern Medical Center, Children's Mercy Hospital Kansas City

Conditions

Cystic FibrosisGrowth Hormone DeficiencyHypopituitarismKidney Failure, ChronicLoss of Chromosome 18qPrader-Willi SyndromeSepto-Optic Dysplasia

Phase 1

Growth Hormone Therapy for Wasting in Cystic Fibrosis

TerminatedNCT00803179

University of Massachusetts, WorcesterCystic Fibrosis

Start: 2008-11-30End: 2012-03-31Updated: 2025-12-02

Phase 2

Growth Hormone Treatment Study in Children With Cystic Fibrosis

WithdrawnNCT00256555

University of Texas Southwestern Medical CenterCystic Fibrosis

Start: 2000-02-29End: 2018-12-12Updated: 2019-01-10

Phase 3

Growth Hormone and Chromosome 18q- and Abnormal Growth

CompletedNCT00134420

The University of Texas Health Science Center at San AntonioGrowth Hormone Deficiency, Loss of Chromosome 18q

Start: 2001-02-28End: 2005-06-30Updated: 2016-08-08

Growth Hormone Use in Adults With Prader-Willi Syndrome

CompletedNCT00444964

Children's Mercy Hospital Kansas CityPrader-Willi Syndrome

Start: 2005-04-30End: 2012-01-01Updated: 2021-01-08

Phase 4

Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia

CompletedNCT00140413

Children's Hospital Los AngelesGrowth Hormone Deficiency, Hypopituitarism, Septo-Optic Dysplasia

Start: 2004-12-31End: 2014-02-28Updated: 2015-04-01

A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood

CompletedNCT00212758

Oregon Health and Science UniversityGrowth Hormone Deficiency, Kidney Failure, Chronic

Start: 2005-01-31End: 2010-05-31Updated: 2011-10-26